HYBRID EVENT
September 14-16, 2026 | Rome, Italy

Plant-Based Vaccines

Plant-Based Vaccines

Plant-based vaccines represent a novel approach to vaccine development, utilizing plants to produce antigens that can stimulate immune responses. This technology harnesses the natural biological systems of plants to express and accumulate specific proteins from pathogens, such as viruses or bacteria. The advantages of plant-based vaccines include scalability, cost-effectiveness, and safety, as they can be produced without the risk of contamination with human pathogens. Moreover, oral delivery of these vaccines can induce mucosal immunity, providing additional protection. Research in this area aims to develop vaccines for diseases affecting humans, livestock, and crops, contributing to public health and agricultural sustainability.

Committee Members
Speaker at Plant Science and Molecular Biology 2026 - Rajnish Khanna

Rajnish Khanna

Visiting Scientist, Stanford University & CEO, i-Cultiver, United States
Speaker at Plant Science and Molecular Biology 2026 - Usha R Palaniswamy

Usha R Palaniswamy

Maria College, United States
Speaker at Plant Science and Molecular Biology 2026 - Jeremy Sweet

Jeremy Sweet

Sweet Environmental Consultants, United Kingdom
GPMB 2026 Speakers
Speaker at Plant Science and Molecular Biology 2026 - Franco Paolinelli

Franco Paolinelli

SAP – Silvicultura Agrocultura Paesaggio (NGO), Italy
Speaker at Plant Science and Molecular Biology 2026 - Eva Kunnemann

Eva Kunnemann

Independent Researcher, Switzerland
Speaker at Plant Science and Molecular Biology 2026 - Rachel Amir

Rachel Amir

Tel Hai University, Israel
Speaker at Plant Science and Molecular Biology 2026 - Teja Sri Vengala

Teja Sri Vengala

Rare Earth Genomics, United States

Submit your abstract Today

WhatsApp